Search

Search Results

• Fish oil supplementation in rheumatoid arthritis

  C. Sales, F. Oliviero, P. Spinella

  174-179

  https://doi.org/10.4081/reumatismo.2008.174

  1847

  PDF: 1276

• Thumb troubles in rheumatoid arthritis

  E. Filippucci, G. Garofalo, W. Grassi

  211-214

  https://doi.org/10.4081/reumatismo.2004.211

  1055

  PDF: 1630
• 

  Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

  M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

  29-12-2022

  https://doi.org/10.4081/reumatismo.2022.1511

  1850

  PDF: 782
• 

  Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

  Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

  29-01-2025

  https://doi.org/10.4081/reumatismo.2025.1754

  987

  PDF: 8

  SUPPLEMENTARY MATERIAL: 86

• Safety of methotrexate in rheumatoid arthritis: a retrospective cohort study in clinical practice

  G. La Montagna, R. Tirri, R. Vitiello, D. Malesci, R. Buono, G. Mennillo, G. Valentini

  261-267

  https://doi.org/10.4081/reumatismo.2006.261

  1176

  PDF: 692

• Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

  M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

  41-49

  https://doi.org/10.4081/reumatismo.2008.41

  1154

  PDF: 772
• 

  Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs

  L. Degli Esposti, V. Perrone, D. Sangiorgi, L. Sinigaglia

  5-14

  19-04-2021

  https://doi.org/10.4081/reumatismo.2021.1329

  3712

  PDF: 523

• Switching between TNFα antagonists in rheumatoid arthritis: personal experience and review of the literature

  R. Scrivo, F. Conti, F.R. Spinelli, S. Truglia, L. Magrini, M. Di Franco, F. Ceccarelli, G. Valesini

  107-117

  https://doi.org/10.4081/reumatismo.2009.107

  1887

  PDF: 1118

• Subclinical atherosclerosis in young patients with rheumatoid arthritis and low disease activity

  E. Bartoloni Bocci, S. Marchesi, F. Delle Monache, G. Vaudo, A. Giordano, F. Ragni Alunni, C. Angrisani, E. Mannarino, Y. Shoenfeld, R. Gerli

  16-21

  https://doi.org/10.4081/reumatismo.2005.16

  941

  PDF: 840
• 

  Treatment patterns of snti-TNF agents in Italy: an observational study

  L. Punzi, M. Matucci Cerinic, F. Cantini, G. Bagnato, U. Fiocco, C. Ferri, S. Bombardieri

  18-28

  https://doi.org/10.4081/reumatismo.2011.18

  1278

  PDF: 937

• Usefulness of anti-cyclic citrullinate peptide antibody determination in synovial fluid analysis of patients with rheumatoid arthritis

  A. Spadaro, V. Riccieri, C. Alessandri, R. Scrivo, G. Valesini

  116-120

  https://doi.org/10.4081/reumatismo.2006.116

  1191

  PDF: 1159

• “THE LEEDS IDEA”: AN HISTORICAL ACCOUNT OF THE SPONDARTHRITIS CONCEPT

  J.M.H. Moll

  13-18

  https://doi.org/10.4081/reumatismo.2007.1s.13

  797

  PDF: 756

• Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis

  A. Iagnocco, C. Perella, F. Ceccarelli, E. Tripodo, C. Alessandri, L. Magrini, G. Valesini

  233-238

  https://doi.org/10.4081/reumatismo.2006.233

  1014

  PDF: 981

• IL-1Ra: its role in rheumatoid arthritis

  M. Cutolo

  41-45

  https://doi.org/10.4081/reumatismo.2004.1s.41

  1454

  PDF: 2286

• Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2)

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, V. Coletta, C. Montecucco

  12-33

  https://doi.org/10.4081/reumatismo.2010.12

  1487

  PDF: 1194

• Rheumatoid arthritis and atherosclerosis

  B. Seriolo, A. Sulli, B. Burroni, M. Cutolo

  140-146

  https://doi.org/10.4081/reumatismo.2003.140

  1820

  PDF: 2879

• Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis

  M. Gutierrez, E. Filippucci, L. Bugatti, C. Bertolazzi, W. Grassi

  65-68

  https://doi.org/10.4081/reumatismo.2009.65

  1326

  PDF: 1015

• Disability and quality of life of patients with rheumatoid arthritis: assessment and perspectives

  F. Salaffi, A. Stancati

  87-106

  https://doi.org/10.4081/reumatismo.2004.1s.87

  1278

  PDF: 3353
• 

  Occult HBV infection may negatively impact on drug survival in patients with rheumatoid arthritis on treatment with a first biologic drug. An appraisal from the Biologic Apulian Registry (BIOPURE)

  G. Carlino, M. Fornaro, L. Santo, R. Bucci, A. Semeraro, L. Quarta, F. D'Onofrio, A. Marsico, C. Zuccaro, P.C. Falappone, D. Mazzotta, F.P. Cantatore, M. Muratore, F. Iannone

  24-30

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1154

  1549

  PDF: 1062

• short history of anti-rheumatic therapy. IV. Corticosteroids

  G. Pasero, P. Marson

  292-299

  https://doi.org/10.4081/reumatismo.2010.292

  1752

  PDF: 1889

• Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis

  G.L. Erre, A. Tocco, R. Faedda, A. Cossu, A. Carcassi

  118-123

  https://doi.org/10.4081/reumatismo.2004.118

  1030

  PDF: 5819
• 

  A case of false positive Troponin I in a patient affected by cryoglobulinemic vasculitis

  M. Bellan, M. Pirisi, G. Bellomo, P.P. Sainaghi

  40-42

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.941

  1261

  PDF: 716

• Socio-demographic aspects and therapeutic pathways in patients with rheumatoid arthritis in Italy

  F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, C.M. Montecucco

  197-211

  https://doi.org/10.4081/reumatismo.2009.197

  1169

  PDF: 895

• Leishmaniasis in rheumatoid arthritis

  C. Pizzorni, M.E. Secchi, M. Cutolo

  235-239

  https://doi.org/10.4081/reumatismo.2007.235

  1486

  PDF: 957

• Comorbidities in rheumatoid arthritis: analysis of hospital discharge records

  M. Parodi, L. Bensi, T. Maio, G.S. Mela, M.A. Cimmino

  154-160

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.154

  2031

  PDF: 1413
• 

  Association between red cell distribution width and response to methotrexate in rheumatoid arthritis

  M. Bellan, D. Soddu, E. Zecca, A. Croce, R. Bonometti, R. Pedrazzoli, D. Sola, C. Rigamonti, L.M. Castello, G.C. Avanzi, M. Pirisi, P.P. Sainaghi

  16-20

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1243

  1498

  PDF: 706
• 

  GISEA: an Italian biological agents registry in rheumatology

  G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

  155-164

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.155

  2286

  PDF: 1540

• The rehabilitative approach in rheumatoid arthritis

  G. Arioli, S. Maddali Bongi, N. Pappone

  242-248

  https://doi.org/10.4081/reumatismo.2008.242

  1727

  PDF: 1956

• Correlation between radiographic, echographic and MRI changes and rheumatoid arthritis progression

  M.A. Cimmino, M. Parodi, E. Silvestri, G. Garlaschi

  28-40

  https://doi.org/10.4081/reumatismo.2004.1s.28

  960

  PDF: 2929

• Rheumatoid arthritis: frequency of hospitalization and evaluation of economic burden

  A. Ciocci, L. Buratti, G. Coari, M. Di Franco, A.M. Iagnocco, M.T. Mauceri, A. Serio

  215-222

  https://doi.org/10.4081/reumatismo.2001.215

  1075

  PDF: 731

• Prevalence of rheumatoid arthritis in North Sardinia: the Tempio Pausania’s study

  D. Marotto, M.E. Nieddu, A. Cossu, A. Carcassi

  273-276

  https://doi.org/10.4081/reumatismo.2005.273

  775

  PDF: 2256

• Analysis of foot structural damage in rheumatoid arthritis: clinical evaluation by validated measures and serological correlations

  D. Biscontini, E. Bartoloni Bocci, R. Gerli

  48-53

  https://doi.org/10.4081/reumatismo.2009.48

  1404

  PDF: 969

• Prevalence of anti-CCP antibodies in systemic sclerosis

  M. Marrone, A. Chialà, M. Tampoia, F. Iannone, L. Raho, M. Covelli, V. Grattagliano, N. Pansini, G. Lapadula

  20-24

  https://doi.org/10.4081/reumatismo.2007.20

  1119

  PDF: 831

• Analysis of the kinetic of expression of tristetraprolin and HuR by rheumatoid arthritis patients pheripheral blood mononuclear cells stimulated with lipopolysaccharide

  M. Fabris, B. Tolusso, E. Gremese, P. Tomietto, G. Ferraccioli

  94-103

  https://doi.org/10.4081/reumatismo.2004.94

  1327

  PDF: 918
• 

  Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study

  M. Rossini, O. Viapiana, M. Vitiello, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, R. Nuti, C.U. Manzini, C. Ferri, L. Bogliolo, A. Mathieu, F. Cantatore, A. Del Puente, M. Muratore, W. Grassi, B. Frediani, G. Saviola, P. Delvino, L. Mirone, G. Ferraccioli, G. Tripi, I. Piazza, D. Gatti

  30-39

  22-05-2017

  https://doi.org/10.4081/reumatismo.2017.922

  4445

  PDF: 2990

• Systemic lupus erythematosus induced by anti-tumor necrosis factor α therapy in inflammatory rheumatic diseases: a case series

  D. Oliveira, A. Martins, F. Martins, C. Gomes, S. Pimenta, C. Vaz, L. Costa, M. Bernardes

  24-09-2024

  https://doi.org/10.4081/reumatismo.2024.1658

  796

  PDF: 191
• 

  Cardiovascular involvement in psoriatic arthritis

  F. Atzeni, M. Turiel, L. Boccassini, S. Sitia, L. Tomasoni, M. Battellino, A. Marchesoni, V. De Gennaro Colonna, P. Sarzi-Puttini

  148-154

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.148

  1904

  PDF: 959

• Stress response system and personality in rheumatoid arthritis patients

  C. Prete, F. Briano, C. Pizzorni, A. Sulli, M. Marcenaro, M. Cutolo

  204-209

  https://doi.org/10.4081/reumatismo.2001.204

  1351

  PDF: 877

• Unexpected and persistent depletion of B lymphocytes CD20 following a minimum dose of anti-CD20 antibody (Rituximab)

  V. Bruzzese, J. Pepe

  306-308

  https://doi.org/10.4081/reumatismo.2009.306

  945

  PDF: 762

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  https://doi.org/10.4081/reumatismo.2005.267

  1043

  PDF: 1654

• Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?

  A.R. Giardina, A. Accardo-Palumbo, F. Ciccia, A. Ferrante, A. Principato, R. Impastato, G. Triolo

  21-26

  https://doi.org/10.4081/reumatismo.2009.21

  1406

  PDF: 1085

• Citrullination: the loss of tolerance and development of autoimmunity in rheumatoid arthritis

  S. Alivernini, A.L. Fedele, I. Cuoghi, B. Tolusso, G. Ferraccioli

  85-94

  https://doi.org/10.4081/reumatismo.2008.85

  1407

  PDF: 1095

• Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab

  Giuseppe D'Alessandro, Maria Rosaria Bianco, Spiridon Politis, Celestino Ferrandina, Giuseppe Rossi, Emanuele Altomare

  59-61

  https://doi.org/10.4081/reumatismo.2006.59

  890

  PDF: 879
• 

  Psoriasis and family history of psoriasis may not affect disease severity of rheumatoid arthritis

  N. Şen, R. Mercan, G. Geçmez, B. Ediz, O. Volkan, S. Yilmaz-Oner, M.E. Tezcan

  07-02-2022

  https://doi.org/10.4081/reumatismo.2021.1453

  5679

  PDF: 638

• Early rheumatoid arthritis

  F. Atzeni, P. Sarzi-Puttini

  100-117

  https://doi.org/10.4081/reumatismo.2007.100

  1474

  PDF: 2087

• Sustained response to infliximab treatment in two cases of early rheumatoid arthritis that has been maintained after drug withdrawal

  P. Caramaschi, S. Pieropan, A. Volpe, A. Carletto, L.M Bambara, D. Biasi

  221-223

  https://doi.org/10.4081/reumatismo.2008.221

  758

  PDF: 1319

• Occupational therapy in rheumatoid arthritis: short term prospective study in patients treated with anti-TNF-alpha drugs

  F. Pasqui, L. Mastrodonato, F. Ceccarelli, R. Scrivo, L. Magrini, V. Riccieri, M. Di Franco, M. Gentili, G. Valesini, A. Spadaro

  191-198

  https://doi.org/10.4081/reumatismo.2006.191

  1806

  PDF: 1555

• Advances in immunology and rheumatoid arthritis pathogenesis

  G. Valesini, F. Barone, D. Bompanone, M. Catuogno, A. Sili Scavalli

  9-20

  https://doi.org/10.4081/reumatismo.2004.1s.9

  1984

• Cardiac involvement in rheumatoid arthritis

  M. Turiel, S. Sitia, L. Tomasoni, S. Cicala, F. Atzeni, L. Gianturco, M. Longhi, V. De Gennaro Colonna, P. Sarzi-Puttini

  244-253

  https://doi.org/10.4081/reumatismo.2009.244

  1915

  PDF: 1326
• 

  Hand dominance in early and established rheumatoid arthritis: evaluation by dynamometer, Ritchie index and musculoskeletal ultrasound: a cross sectional study

  A.M. Elsaman, A. Sayed, A.R. Radwan

  131-144

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1273

  1321

  PDF: 717